Eluxadoline + Cyclosporine Interaction
Moderateinteraction on record
Description
OATP1B1 inhibitor that increases eluxadoline exposure. Requires dose reduction to 75 mg twice daily and monitoring for adverse reactions.
Mechanism
OATP1B1 inhibition
Source: NLP:eluxadoline